Agile therapeutics reports fourth quarter & full year 2022 financial results and provides corporate update

Fourth quarter 2022 net revenue increased 33% from third quarter 2022 while gaap quarter-over-quarter opex decreased 55% and non-gaap opex remained unchanged

AGRX Ratings Summary

AGRX Quant Ranking